SIMILAR PATTERNS OF AMINO ACIDS FOR 6DJ1_B_AB1B201_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
5 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 6dj1B-1bouB:
undetectable
6dj1B-1bouB:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
6 GLY A  40
ALA A  39
ASP A  38
VAL A 324
ILE A  35
ILE A  44
None
1.16A 6dj1B-1fobA:
undetectable
6dj1B-1fobA:
11.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
0.59A 6dj1B-1hvcA:
13.7
6dj1B-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
0.66A 6dj1B-1hvcA:
13.7
6dj1B-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
VAL A  82
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
0.62A 6dj1B-1hvcA:
13.7
6dj1B-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
PRO A  81
VAL A  82
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
0.61A 6dj1B-1hvcA:
13.7
6dj1B-1hvcA:
41.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i8f PUTATIVE SNRNP
SM-LIKE PROTEIN


(Pyrobaculum
aerophilum)
PF01423
(LSM)
5 GLY A  64
VAL A  68
ILE A  34
GLY A  36
ILE A  37
None
0.93A 6dj1B-1i8fA:
undetectable
6dj1B-1i8fA:
19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p2f RESPONSE REGULATOR

(Thermotoga
maritima)
PF00072
(Response_reg)
PF00486
(Trans_reg_C)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  75
ILE A  61
None
0.79A 6dj1B-1p2fA:
undetectable
6dj1B-1p2fA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8y SR PROTEIN KINASE

(Saccharomyces
cerevisiae)
PF00069
(Pkinase)
5 ARG A 287
ASP A 282
GLY A 698
ALA A 697
GLY A 726
None
0.93A 6dj1B-1q8yA:
undetectable
6dj1B-1q8yA:
12.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
None
0.38A 6dj1B-1q9pA:
10.1
6dj1B-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
None
0.81A 6dj1B-1q9pA:
10.1
6dj1B-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
0.64A 6dj1B-1sivA:
18.7
6dj1B-1sivA:
49.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vrg PROPIONYL-COA
CARBOXYLASE, BETA
SUBUNIT


(Thermotoga
maritima)
PF01039
(Carboxyl_trans)
6 GLY A 416
ALA A 417
ASP A 418
ILE A 395
ILE A 346
VAL A 360
None
1.11A 6dj1B-1vrgA:
undetectable
6dj1B-1vrgA:
12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x0u HYPOTHETICAL
METHYLMALONYL-COA
DECARBOXYLASE ALPHA
SUBUNIT


(Sulfurisphaera
tokodaii)
PF01039
(Carboxyl_trans)
6 GLY A 424
ALA A 425
ASP A 426
ILE A 403
ILE A 354
VAL A 368
None
1.17A 6dj1B-1x0uA:
undetectable
6dj1B-1x0uA:
9.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xqi NUCLEOSIDE
DIPHOSPHATE KINASE


(Pyrobaculum
aerophilum)
PF00334
(NDK)
6 ARG A 165
ASP A  25
ALA A  26
VAL A 171
ILE A 148
ILE A 154
None
1.47A 6dj1B-1xqiA:
undetectable
6dj1B-1xqiA:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yr2 PROLYL
OLIGOPEPTIDASE


(Novosphingobium
capsulatum)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 539
ALA A 538
ASP A 537
GLY A 529
PRO A 475
VAL A 474
None
1.09A 6dj1B-1yr2A:
undetectable
6dj1B-1yr2A:
7.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yw6 SUCCINYLGLUTAMATE
DESUCCINYLASE


(Escherichia
coli)
PF04952
(AstE_AspA)
5 ARG A 250
GLY A 180
ALA A 179
GLY A 242
ILE A 243
None
0.89A 6dj1B-1yw6A:
undetectable
6dj1B-1yw6A:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bkl PROLYL ENDOPEPTIDASE

(Myxococcus
xanthus)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 497
ALA A 496
ASP A 495
GLY A 487
PRO A 431
VAL A 430
None
1.10A 6dj1B-2bklA:
undetectable
6dj1B-2bklA:
10.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2czd OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE


(Pyrococcus
horikoshii)
PF00215
(OMPdecase)
5 GLY A  78
ALA A  79
ASP A  80
ILE A  55
ILE A  42
None
0.96A 6dj1B-2czdA:
undetectable
6dj1B-2czdA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eja UROPORPHYRINOGEN
DECARBOXYLASE


(Aquifex
aeolicus)
PF01208
(URO-D)
5 GLY A 192
ALA A 193
ASP A 194
ILE A 134
ILE A 120
None
0.75A 6dj1B-2ejaA:
undetectable
6dj1B-2ejaA:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
PRO A  86
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
0.58A 6dj1B-2fmbA:
15.0
6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
0.59A 6dj1B-2fmbA:
15.0
6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
PRO A  86
VAL A  87
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
0.55A 6dj1B-2fmbA:
15.0
6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
0.94A 6dj1B-2fmbA:
15.0
6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjg PUTATIVE ALDOLASE
MJ0400


(Methanocaldococcus
jannaschii)
PF01791
(DeoC)
5 GLY A 179
ALA A 180
ASP A 181
ILE A 149
VAL A 120
None
0.90A 6dj1B-2qjgA:
undetectable
6dj1B-2qjgA:
15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qma DIAMINOBUTYRATE-PYRU
VATE TRANSAMINASE
AND
L-2,4-DIAMINOBUTYRAT
E DECARBOXYLASE


(Vibrio
parahaemolyticus)
PF00282
(Pyridoxal_deC)
5 GLY A 728
ALA A 727
ASP A 755
VAL A 774
ILE A 780
None
0.92A 6dj1B-2qmaA:
undetectable
6dj1B-2qmaA:
10.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
0.54A 6dj1B-2rkfA:
20.5
6dj1B-2rkfA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ARG A  10
ASP A  37
GLY A  39
ALA A  40
ASP A  41
None
0.80A 6dj1B-2rspA:
12.7
6dj1B-2rspA:
30.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wk1 NOVP

(Actinoalloteichus
cyanogriseus)
PF05711
(TylF)
5 GLY A  28
ALA A  27
ILE A  66
GLY A  99
ILE A 102
None
None
SAH  A 301 (-4.1A)
None
None
0.96A 6dj1B-2wk1A:
undetectable
6dj1B-2wk1A:
15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a1i AMIDASE

(Rhodococcus sp.
N-771)
PF01425
(Amidase)
6 GLY A 174
ALA A 139
VAL A  93
ILE A  95
GLY A 189
ILE A 196
None
1.36A 6dj1B-3a1iA:
undetectable
6dj1B-3a1iA:
10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3afo NADH KINASE POS5

(Saccharomyces
cerevisiae)
PF01513
(NAD_kinase)
5 ALA A  48
ASP A  49
ILE A  62
ILE A 195
VAL A 383
None
0.95A 6dj1B-3afoA:
undetectable
6dj1B-3afoA:
11.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c24 PUTATIVE
OXIDOREDUCTASE


(Jannaschia sp.
CCS1)
PF03807
(F420_oxidored)
PF16896
(PGDH_C)
5 GLY A 164
ALA A 165
ILE A 149
GLY A 120
ILE A 119
None
0.89A 6dj1B-3c24A:
undetectable
6dj1B-3c24A:
13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.90A 6dj1B-3i5gA:
undetectable
6dj1B-3i5gA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igs N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE 2


(Salmonella
enterica)
PF04131
(NanE)
5 GLY A 146
ALA A 147
ASP A 148
VAL A 104
ILE A 122
None
0.85A 6dj1B-3igsA:
undetectable
6dj1B-3igsA:
16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ipw HYDROLASE TATD
FAMILY PROTEIN


(Entamoeba
histolytica)
PF01026
(TatD_DNase)
5 GLY A 112
ASP A  55
GLY A   9
ILE A   8
VAL A  75
None
0.79A 6dj1B-3ipwA:
undetectable
6dj1B-3ipwA:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kci PROBABLE E3
UBIQUITIN-PROTEIN
LIGASE HERC2


(Homo sapiens)
PF00415
(RCC1)
5 GLY A4099
ALA A4098
VAL A4042
ILE A3991
GLY A3993
None
0.83A 6dj1B-3kciA:
undetectable
6dj1B-3kciA:
12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kf3 INVERTASE

(Schwanniomyces
occidentalis)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP A 287
GLY A 289
ASP A 291
ILE A 485
PRO A 355
None
None
None
None
NAG  A5001 ( 4.9A)
0.90A 6dj1B-3kf3A:
undetectable
6dj1B-3kf3A:
10.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
None
0.80A 6dj1B-3mwsA:
19.6
6dj1B-3mwsA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
None
0.54A 6dj1B-3mwsA:
19.6
6dj1B-3mwsA:
76.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n0l SERINE
HYDROXYMETHYLTRANSFE
RASE


(Campylobacter
jejuni)
PF00464
(SHMT)
5 GLY A 206
ALA A 205
ILE A 199
PRO A 360
VAL A 284
None
0.96A 6dj1B-3n0lA:
undetectable
6dj1B-3n0lA:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3njx RHAMNOGALACTURONASE
B


(Aspergillus
aculeatus)
PF09284
(RhgB_N)
PF14683
(CBM-like)
PF14686
(fn3_3)
5 GLY A 346
ASP A 349
VAL A 336
GLY A 420
ILE A 419
None
CA  A 800 (-2.9A)
None
None
None
0.95A 6dj1B-3njxA:
undetectable
6dj1B-3njxA:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nns DNA BINDING RESPONSE
REGULATOR B


(Thermotoga
maritima)
PF00072
(Response_reg)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  75
ILE A  61
None
0.81A 6dj1B-3nnsA:
undetectable
6dj1B-3nnsA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
6 GLY A 224
ALA A 225
ASP A 226
ILE A 260
ILE A 192
VAL A 207
PO4  A 767 ( 4.6A)
None
None
None
None
None
1.22A 6dj1B-3o8lA:
undetectable
6dj1B-3o8lA:
8.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8o 6-PHOSPHOFRUCTOKINAS
E SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00365
(PFK)
6 GLY A 414
ALA A 415
ASP A 416
ILE A 451
ILE A 382
VAL A 397
None
1.30A 6dj1B-3o8oA:
undetectable
6dj1B-3o8oA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pqs TRANSFERRIN-BINDING
PROTEIN


(Actinobacillus
pleuropneumoniae)
PF01298
(TbpB_B_D)
PF17483
(TbpB_C)
PF17484
(TbpB_A)
6 GLY A 463
ALA A 454
ASP A 455
VAL A 429
ILE A 456
GLY A 460
None
1.09A 6dj1B-3pqsA:
undetectable
6dj1B-3pqsA:
10.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pqu TRANSFERRIN BINDING
PROTEIN B


(Actinobacillus
suis)
PF01298
(TbpB_B_D)
PF17483
(TbpB_C)
PF17484
(TbpB_A)
5 GLY A 512
ALA A 503
VAL A 478
ILE A 505
GLY A 509
None
0.95A 6dj1B-3pquA:
undetectable
6dj1B-3pquA:
8.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r1x 2-OXO-3-DEOXYGALACTO
NATE KINASE


(Klebsiella
pneumoniae)
PF05035
(DGOK)
6 GLY A 118
ALA A  64
ASP A   9
VAL A  62
ILE A 283
GLY A 282
None
1.33A 6dj1B-3r1xA:
undetectable
6dj1B-3r1xA:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.58A 6dj1B-3slzA:
11.0
6dj1B-3slzA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
PRO A  89
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.73A 6dj1B-3slzA:
11.0
6dj1B-3slzA:
23.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.82A 6dj1B-3t3cA:
18.1
6dj1B-3t3cA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.93A 6dj1B-3t3cA:
18.1
6dj1B-3t3cA:
76.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t44 INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE


(Mycobacterium
tuberculosis)
PF00218
(IGPS)
5 GLY A 235
ALA A 236
ASP A 237
ILE A 217
ILE A 206
None
0.71A 6dj1B-3t44A:
undetectable
6dj1B-3t44A:
15.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.46A 6dj1B-3ttpA:
19.3
6dj1B-3ttpA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
1.42A 6dj1B-3u7sA:
19.7
6dj1B-3u7sA:
77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.73A 6dj1B-3u7sA:
19.7
6dj1B-3u7sA:
77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.61A 6dj1B-3uhlA:
15.9
6dj1B-3uhlA:
81.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wn6 ALPHA-AMYLASE

(Oryza sativa)
PF00128
(Alpha-amylase)
PF07821
(Alpha-amyl_C2)
6 ARG A 368
GLY A 393
ILE A 409
GLY A 412
ILE A 428
VAL A 416
None
1.24A 6dj1B-3wn6A:
undetectable
6dj1B-3wn6A:
12.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2o YMDB
PHOSPHODIESTERASE


(Bacillus
subtilis)
PF13277
(YmdB)
5 GLY A  59
ALA A  60
ASP A  61
ILE A  35
VAL A   9
None
0.73A 6dj1B-4b2oA:
undetectable
6dj1B-4b2oA:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dzh AMIDOHYDROLASE

(Xanthomonas
campestris)
PF01979
(Amidohydro_1)
5 ALA A 355
ILE A  25
GLY A 370
ILE A 369
VAL A 381
None
0.93A 6dj1B-4dzhA:
undetectable
6dj1B-4dzhA:
11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ezd UREA TRANSPORTER 1

(Bos taurus)
PF03253
(UT)
5 GLY A 333
VAL A  64
ILE A 228
GLY A 230
ILE A 130
SEY  A 401 (-3.6A)
None
None
SEY  A 401 ( 4.0A)
None
0.92A 6dj1B-4ezdA:
undetectable
6dj1B-4ezdA:
11.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h2l ALPHA-GLOBIN

(Peromyscus
maniculatus)
PF00042
(Globin)
5 ASP A  64
GLY A  60
ALA A  63
ILE A  17
GLY A  19
None
0.95A 6dj1B-4h2lA:
undetectable
6dj1B-4h2lA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ict CYTOCHROME P450 121

(Mycobacterium
tuberculosis)
PF00067
(p450)
5 ARG A 184
GLY A 191
ALA A 190
ASP A 220
GLY A 227
None
0.82A 6dj1B-4ictA:
undetectable
6dj1B-4ictA:
11.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ilk STARVATION SENSING
PROTEIN RSPB


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 206
ALA A 207
ASP A 208
ILE A 190
ILE A 176
None
0.75A 6dj1B-4ilkA:
undetectable
6dj1B-4ilkA:
14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j5u SERINE
HYDROXYMETHYLTRANSFE
RASE


(Rickettsia
rickettsii)
PF00464
(SHMT)
5 ALA A 173
ASP A 201
VAL A 224
ILE A 202
PRO A 219
None
LLP  A 230 ( 2.9A)
None
None
None
0.93A 6dj1B-4j5uA:
undetectable
6dj1B-4j5uA:
12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jga 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 2


(Rickettsia
rickettsii)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 276
ALA A 301
ASP A 304
ILE A 273
ILE A 184
None
0.94A 6dj1B-4jgaA:
undetectable
6dj1B-4jgaA:
10.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m98 PILIN GLYCOSYLATION
PROTEIN


(Neisseria
gonorrhoeae)
PF00132
(Hexapep)
5 GLY A 302
VAL A 295
ILE A 289
ILE A 324
VAL A 331
None
0.93A 6dj1B-4m98A:
undetectable
6dj1B-4m98A:
18.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
0.83A 6dj1B-4njvA:
20.1
6dj1B-4njvA:
86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
0.58A 6dj1B-4njvA:
20.1
6dj1B-4njvA:
86.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1e DIHYDROPTEROATE
SYNTHASE DHPS


(Desulfitobacterium
hafniense)
PF00809
(Pterin_bind)
5 ARG A  34
GLY A  39
ALA A  40
ASP A  41
ILE A   5
None
0.91A 6dj1B-4o1eA:
undetectable
6dj1B-4o1eA:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqj PKS

(Streptomyces
albus)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
5 GLY A 672
ALA A 671
GLY A 666
ILE A 665
VAL A 545
None
0.85A 6dj1B-4oqjA:
undetectable
6dj1B-4oqjA:
8.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pcg VP1

(Human
polyomavirus 6)
PF00718
(Polyoma_coat)
6 ALA A 194
ASP A 144
VAL A 182
GLY A 147
ILE A 148
PRO A 188
None
1.44A 6dj1B-4pcgA:
undetectable
6dj1B-4pcgA:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pcg VP1

(Human
polyomavirus 6)
PF00718
(Polyoma_coat)
6 ALA A 194
ASP A 195
ASP A 144
VAL A 182
GLY A 147
PRO A 188
None
1.29A 6dj1B-4pcgA:
undetectable
6dj1B-4pcgA:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pch VP1

(Human
polyomavirus 7)
PF00718
(Polyoma_coat)
6 ALA A 191
ASP A 192
ASP A 144
VAL A 179
GLY A 147
PRO A 185
None
1.31A 6dj1B-4pchA:
undetectable
6dj1B-4pchA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4phq HEMOLYSIN E,
CHROMOSOMAL


(Escherichia
coli)
PF06109
(HlyE)
5 GLY A  22
ALA A  23
ILE A 247
ILE A 253
VAL A 119
None
0.87A 6dj1B-4phqA:
undetectable
6dj1B-4phqA:
11.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q0g PROBABLE
ACETYL-/PROPIONYL-CO
A CARBOXYLASE (BETA
SUBUNIT) ACCD1


(Mycobacterium
tuberculosis)
PF01039
(Carboxyl_trans)
5 ASP A 290
VAL A 287
GLY A 409
ILE A 370
VAL A 297
None
0.90A 6dj1B-4q0gA:
undetectable
6dj1B-4q0gA:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tqk LECTIN 2

(Agrocybe
aegerita)
PF13517
(VCBS)
5 ASP A 345
GLY A 350
ASP A 290
VAL A 343
GLY A 371
None
0.93A 6dj1B-4tqkA:
undetectable
6dj1B-4tqkA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4us4 TRANSPORTER

(Bacillus
halodurans)
PF00209
(SNF)
5 GLY A 396
ALA A  93
VAL A  78
PRO A 332
VAL A 331
None
0.95A 6dj1B-4us4A:
undetectable
6dj1B-4us4A:
11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ARG A  10
ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
0.58A 6dj1B-4ydfA:
12.5
6dj1B-4ydfA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
GLY A  58
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
4B1  A 201 (-3.4A)
0.59A 6dj1B-4ydfA:
12.5
6dj1B-4ydfA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywk CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
6 GLY A 225
VAL A 221
ILE A 187
GLY A 205
ILE A 206
VAL A 214
None
1.16A 6dj1B-4ywkA:
undetectable
6dj1B-4ywkA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 ARG A  94
VAL A 221
ILE A 187
GLY A 205
ILE A 206
None
0.85A 6dj1B-4ywlA:
undetectable
6dj1B-4ywlA:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 GLY A 225
VAL A 221
ILE A 187
GLY A 205
ILE A 206
None
0.75A 6dj1B-4ywlA:
undetectable
6dj1B-4ywlA:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 VAL A 221
ILE A 187
GLY A 205
ILE A 206
VAL A 214
None
0.93A 6dj1B-4ywlA:
undetectable
6dj1B-4ywlA:
17.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
None
0.69A 6dj1B-5b18A:
18.0
6dj1B-5b18A:
73.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gw5 T-COMPLEX PROTEIN 1
SUBUNIT EPSILON


(Saccharomyces
cerevisiae)
PF00118
(Cpn60_TCP1)
5 GLY e 317
ALA e 318
ASP e 319
GLY e 375
VAL e 363
None
0.93A 6dj1B-5gw5e:
undetectable
6dj1B-5gw5e:
11.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h6s AMIDASE

(Microbacterium
sp. HM58-2)
PF01425
(Amidase)
6 GLY A 124
ALA A 123
ASP A  81
ILE A  79
GLY A 173
VAL A 163
None
1.48A 6dj1B-5h6sA:
undetectable
6dj1B-5h6sA:
10.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h9d FARNESYL
PYROPHOSPHATE
SYNTHETASE


(Staphylococcus
aureus)
PF00348
(polyprenyl_synt)
5 ASP A 209
ASP A 210
ILE A 165
GLY A 202
ILE A 201
None
0.93A 6dj1B-5h9dA:
undetectable
6dj1B-5h9dA:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5inf CARBOXYL TRANSFERASE

(Streptomyces
ambofaciens)
PF01039
(Carboxyl_trans)
5 GLY A 431
ALA A 432
ASP A 433
ILE A 410
ILE A 361
None
0.86A 6dj1B-5infA:
undetectable
6dj1B-5infA:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4l CERULOPLASMIN

(Rattus
norvegicus)
no annotation 5 ALA A 102
VAL A  88
ILE A  78
GLY A 175
ILE A 174
None
0.84A 6dj1B-5n4lA:
undetectable
6dj1B-5n4lA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o32 COMPLEMENT FACTOR I

(Homo sapiens)
PF00089
(Trypsin)
5 GLY I 526
ASP I 429
VAL I 562
ILE I 430
ILE I 375
None
0.96A 6dj1B-5o32I:
undetectable
6dj1B-5o32I:
16.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  50
PRO A  81
None
0.60A 6dj1B-5t2zA:
20.2
6dj1B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
0.54A 6dj1B-5t2zA:
20.2
6dj1B-5t2zA:
80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uak CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR


(Homo sapiens)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
PF14396
(CFTR_R)
5 GLY A1123
ILE A 105
GLY A1130
ILE A1131
VAL A1114
None
0.93A 6dj1B-5uakA:
undetectable
6dj1B-5uakA:
3.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ufm METHYLTRANSFERASE
DOMAIN PROTEIN


(Burkholderia
thailandensis)
no annotation 5 ASP A  95
GLY A  76
ASP A  72
VAL A 120
GLY A 136
SAH  A 301 (-2.7A)
SAH  A 301 (-3.6A)
None
SAH  A 301 (-4.1A)
AZ8  A 302 ( 3.5A)
0.89A 6dj1B-5ufmA:
undetectable
6dj1B-5ufmA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x88 CUTINASE

(Malbranchea
cinnamomea)
no annotation 6 GLY A 114
ALA A 115
VAL A 136
ILE A 151
GLY A 120
ILE A  87
None
1.33A 6dj1B-5x88A:
undetectable
6dj1B-5x88A:
22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A  13
ASP A  30
GLY A  32
ALA A  33
ASP A  34
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
None
0.75A 6dj1B-6fivA:
15.6
6dj1B-6fivA:
30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.24A 6dj1B-6fivA:
15.6
6dj1B-6fivA:
30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
0.83A 6dj1B-6upjA:
17.8
6dj1B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
1.49A 6dj1B-6upjA:
17.8
6dj1B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.81A 6dj1B-6upjA:
17.8
6dj1B-6upjA:
47.50